Holdings (as at 2024-11-29) | Show Index Holdings
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.95%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2024-11-29)
Security Name % of Net Assets
Exelixis, Inc. 4.58%
Natera, Inc. 4.25%
Corcept Therapeutics Incorporated 4.18%
argenx SE (ADR) 3.78%
Incyte Corporation 3.72%
Intra-Cellular Therapies, Inc. 3.72%
Neurocrine Biosciences, Inc. 3.62%
ACADIA Pharmaceuticals Inc. 3.60%
Catalyst Pharmaceuticals, Inc. 3.60%
Gilead Sciences, Inc. 3.59%
Repligen Corporation 3.57%
Waters Corporation 3.54%
Sarepta Therapeutics, Inc. 3.53%
United Therapeutics Corporation 3.41%
Alkermes Plc 3.31%
Illumina, Inc. 3.26%
BioNTech SE (ADR) 3.24%
Vertex Pharmaceuticals Incorporated 3.20%
BioMarin Pharmaceutical Inc. 3.09%
Genmab A/S (ADR) 3.01%
BeiGene, Ltd. (ADR) 3.00%
Halozyme Therapeutics, Inc. 3.00%
Bruker Corporation 2.96%
Alnylam Pharmaceuticals, Inc. 2.93%
Exact Sciences Corporation 2.88%
Amgen Inc. 2.84%
Mettler-Toledo International Inc. 2.84%
Biogen Inc. 2.81%
Moderna, Inc. 2.43%
Regeneron Pharmaceuticals, Inc. 2.43%
Dreyfus Government Cash Management (Institutional Shares) 0.16%
US Dollar -0.04%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.